Skip to main content
Equibles

Aquatic Capital Management LLC

Position in PGEN — Precigen, Inc.

CIK 1803916 CHICAGO, IL
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$698,335
+$695,170 QoQ
Shares Held
122,515
+8067.7% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#79
of 210 holders
Holding Since
Mar 2022
2 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Aquatic Capital Management LLC holds $147,914,673 across 88 Biotechnology names. PGEN ranks #48 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 32,577 $20,313,062
2 CYTK
Cytokinetics Inc
 125,090 $10,656,417
3 TVTX
Travere Therapeutics, Inc.
 157,710 $8,959,505
4 ARGX
Argenx SE
 7,697 $7,141,045
5 PTCT
Ptc Therapeutics, Inc.
 83,470 $6,808,647
6 TGTX
Tg Therapeutics, Inc.
 99,530 $5,468,178
7 ALNY
Alnylam Pharmaceuticals, Inc.
 15,480 $4,659,944
8 MIRM
Mirum Pharmaceuticals, Inc.
 36,670 $4,292,956

All Filings in PGEN

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $698,335 122,515
2022-03-31 $3,165 1,500